Ascendis Pharma A/S (ASND) News
NASDAQ: ASNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
229.23+6.54 (+2.94%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ASND news summary
We found 3 recent headlines mentioning Ascendis Pharma A/S (ASND): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, ASND is up 2.94% at $229.23. The most recent story, "Wednesday's ETF with Unusual Volume: PIEQ", was published by Nasdaq on Sep 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Ascendis Pharma A/S headlines
- Wednesday's ETF with Unusual Volume: PIEQThe Principal International Equity ETF is seeing unusually high volume in afternoon trading Wednesday, with over 421,000 shares traded versus three month average volume of about 34,000. Shares of…NasdaqPIEQ, VALE, TSM, ASND
- Weekly Buzz: IONS, MIST, BIIB, AZN Win Nods; TCRX, NVS Cut Jobs; OVID, VIR Data; REGN, PASG Deals(RTTNews) - This week's biotech roundup saw a flurry of FDA and EU approvals across neurology, oncology, cardiology, and rare diseases, alongside new partnerships, trial readouts, and restructuring…NasdaqAPVO, ASND, AZN, BIIB
- Pre-Market Earnings Report for August 13, 2026 : BN, JD, TPR, ASND, AIT, MSGS, BIRK, GDS, ONDS, CLBT, YETI, BLSHThe following companies are expected to report earnings prior to market open on 08/13/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Brookfield Corporation (BN)is…NasdaqBN, JD, TPR, ASND